SOURCE: The Mapi Group
February 19, 2014 13:31 ET
LEXINGTON, KY--(Marketwired - Feb 19, 2014) - Mapi, the leading expert in Observational Studies, Health Economics and Outcomes Research (HEOR) and Real-World Evidence, announces that Ronald Christensen, M.D., Chief Medical Officer at Mapi and an industry-leading expert in orphan drug development, will make presentations at two major orphan drug conferences. At both events, Dr. Christensen will provide perspectives on the design and implementation of patient registries in orphan drug development, providing specific "lessons learned" to address the inherent challenges of conducting registries in rare disease populations.
Dr. Christensen will speak at the:
Mapi is a leading global organization, offering evaluation and support of therapeutic strategies. With offices worldwide, Mapi provides high quality and efficient operations to help its clients secure product approval and reimbursement while meeting the needs of patients, physicians, regulatory authorities and health care technology purchasers. For more information about Mapi, visit: http://www.mapigroup.com.
See all RSS Newsfeeds